Sporadic occurrences of fluoroquinolone-resistant Streptococcus pneumoniae in the United States: Longitudinal analysis of institutions from the New England and West South Central regions during the TRUST 4-9 (2000-2005) surveillance studies

Postgraduate Medicine

Volumn 120, Issue 3, 2008, Pages

  Davies, Todd A ^a   Yee, Y Cheung ^b   Amsler, Karen ^a   Goldschmidt, Raul ^a   Sahm, Daniel F ^c   Evangelista, Alan T ^b  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

^c Eurofins Medinet Inc   (Germany)

Author keywords

Levofloxacin; New England; Respiratory tract infection; Streptococcus pneumoniae; West South Central

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; HEALTH SURVEY; LONGITUDINAL STUDY; MUTATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS INFECTION;

DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 66849101463     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2008.09.suppl52.281     Document Type: Article

References (14)

1. Bartlett JG, Dowell SF, Mandell LA, File Jr TM, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31(2):347-382.
2. Niederman MS, Mandell LA, Anzueto A, et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163(7):1730-1754. (Pubitemid 32578779)
3. Sahm DF. Resistance issues and community-acquired respiratory infections. Clin Cornerstone. 2003;(suppl 3):S4-S11. (Pubitemid 38195636)
4. Brueggemann AB, Coffman SL, Rhomberg P, et al. Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995. Antimicrob Agents Chemother. 2002;46(3):680-688.
5. Data on file. From 2005 TRUST study. Ortho-McKeil-Janssen Pharmaceuticals, Inc.
6. Brown SD, Farrell DJ, Morrissey I. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study. J Clin Microbiol. 2004;42(11):4980-4987.
7. Karlowsky JA, Thornsberry C, Jones ME, et al. TRUST Surveillance Program. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clin Infect Dis. 2003;36(8):963-970.
8. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard. 7th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2006:1-49.
9. Davies TA, Goldschmidt R, Pfleger S, et al. Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000). J Antimicrob Chemother. 2003;52(2):168-175.
10. Pan XS, Ambler J, Mehtar S, Fisher LM. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996;40(10):2321-2326.
11. Ho PL, Yung RW, Tsang DN, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother. 2001;48(5):659-665.
12. McGee L, Goldsmith CE, Klugman KP. Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. J Antimicrob Chemother. 2002;49(1):173-176. (Pubitemid 34100663)
13. Richter SS, Heilmann KP, Coffman SL, et al. The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000. Clin Infect Dis. 2002;34(3):330-339.
14. 9V-3 among US levofloxacin-resistant Streptococcus pneumoniae isolates from TRUST 3-6 surveillance studies (1998-2002). Presented at: 41st Annual Meeting of the Infectious Diseases Society of America (San Diego); October 2003; Alexandria, VA.